Breaking News, Financial News

Financial Report: INC Research

Revenues up 14% in the quarter

By: Kristin Brooks

Managing Editor, Contract Pharma

INC Research
 
2Q Revenues: $227.4 million (+14%)

2Q Earnings: $23.3 million (+53%)

YTD Revenues: $438.9 million (+13%)

YTD Earnings: $48.6 million (earnings were $13.8 million YTD14)

Comments: Backlog grew by 12% year-over-year to $1.7 billion as of June 30, 2015. Service revenue growth during both the quarter and first half was primarily driven by continued strong awards over the last two years, a lower cancellation rate of previously awarded business and a positive revenue mix. In 2015, revenue grew across all therapeutic areas and has been particularly strong in the CNS, Oncology and other complex therapeutic areas.  

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters